beta-3 adrenergic receptor agonist (OncoPharm)

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug Namebeta-3 adrenergic receptor agonist (OncoPharm)

Drug Alias Namebeta-3 adrenergic receptor agonist (Codon)beta-3 adrenergic receptor agonist (Johns Hopkins)obesity mutant (Codon/Johns Hopkins)obesity mutant (OncoPharm/Johns Hopkins)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBeta-3 adrenergic receptor agonists

TargetsBeta-3 adrenergic receptor

Therapy Area/IndicationsObesity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJohns Hopkins University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCodon Pharmaceuticals Inc Johns Hopkins University

Active IndicationsN/A

Inactive IndicationsObesity

Other Information

ATC CodeN/A